Primary Adrenal Insufficiency during Immune Checkpoint Inhibitor Treatment: Case Reports and Review of the Literature

Carlos Salinas; Alex Renner; Carlos Rojas; Suraj Samtani; Mauricio Burotto

doi:10.1159/000507652

Primary Adrenal Insufficiency during Immune Checkpoint Inhibitor Treatment: Case Reports and Review of the Literature

Carlos Salinas, Alex Renner, Carlos Rojas, Suraj Samtani, Mauricio Burotto^*

^*Autor correspondiente de este trabajo

Clínica Universidad de los Andes

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

13 Citas (Scopus)

Resumen

As the indications and clinical use of immune checkpoint inhibitors increase, it is expected that we will face some of their less frequently reported complications. Primary adrenal insufficiency is one of them, and given its unspecific symptoms and potentially serious consequences, it is important to have a high degree of clinical suspicion. We present 3 cases and a review of the literature concerning its main clinical characteristics, diagnostics, and management.

Idioma original	Inglés
Páginas (desde-hasta)	621-626
Número de páginas	6
Publicación	Case Reports in Oncology
Volumen	13
N.º	2
DOI	https://doi.org/10.1159/000507652
Estado	Publicada - 2020

Nota bibliográfica

Publisher Copyright:
© 2020 S. Karger AG. All rights reserved.

Palabras clave

Immune-related adverse events
Ipilimumab
Nivolumab
Primary adrenal insufficiency

Acceder al documento

10.1159/000507652

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{70cbe14e41e745349db45de063b08bba,

title = "Primary Adrenal Insufficiency during Immune Checkpoint Inhibitor Treatment: Case Reports and Review of the Literature",

abstract = "As the indications and clinical use of immune checkpoint inhibitors increase, it is expected that we will face some of their less frequently reported complications. Primary adrenal insufficiency is one of them, and given its unspecific symptoms and potentially serious consequences, it is important to have a high degree of clinical suspicion. We present 3 cases and a review of the literature concerning its main clinical characteristics, diagnostics, and management. ",

keywords = "Immune-related adverse events, Ipilimumab, Nivolumab, Primary adrenal insufficiency, Immune-related adverse events, Ipilimumab, Nivolumab, Primary adrenal insufficiency",

author = "Carlos Salinas and Alex Renner and Carlos Rojas and Suraj Samtani and Mauricio Burotto",

year = "2020",

doi = "10.1159/000507652",

language = "English",

volume = "13",

pages = "621--626",

journal = "Case Reports in Oncology",

issn = "1662-6575",

publisher = "S. Karger AG",

number = "2",

}

TY - JOUR

T1 - Primary Adrenal Insufficiency during Immune Checkpoint Inhibitor Treatment

T2 - Case Reports and Review of the Literature

AU - Salinas, Carlos

AU - Renner, Alex

AU - Rojas, Carlos

AU - Samtani, Suraj

AU - Burotto, Mauricio

PY - 2020

Y1 - 2020

N2 - As the indications and clinical use of immune checkpoint inhibitors increase, it is expected that we will face some of their less frequently reported complications. Primary adrenal insufficiency is one of them, and given its unspecific symptoms and potentially serious consequences, it is important to have a high degree of clinical suspicion. We present 3 cases and a review of the literature concerning its main clinical characteristics, diagnostics, and management.

AB - As the indications and clinical use of immune checkpoint inhibitors increase, it is expected that we will face some of their less frequently reported complications. Primary adrenal insufficiency is one of them, and given its unspecific symptoms and potentially serious consequences, it is important to have a high degree of clinical suspicion. We present 3 cases and a review of the literature concerning its main clinical characteristics, diagnostics, and management.

KW - Immune-related adverse events

KW - Ipilimumab

KW - Nivolumab

KW - Primary adrenal insufficiency

KW - Immune-related adverse events

KW - Ipilimumab

KW - Nivolumab

KW - Primary adrenal insufficiency

UR - http://www.scopus.com/inward/record.url?scp=85087169863&partnerID=8YFLogxK

U2 - 10.1159/000507652

DO - 10.1159/000507652

M3 - Article

AN - SCOPUS:85087169863

SN - 1662-6575

VL - 13

SP - 621

EP - 626

JO - Case Reports in Oncology

JF - Case Reports in Oncology

IS - 2

ER -

Primary Adrenal Insufficiency during Immune Checkpoint Inhibitor Treatment: Case Reports and Review of the Literature

Resumen

Nota bibliográfica

Palabras clave

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto